Literature DB >> 11427412

Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus.

J M Matthews-Greer1, G C Caldito, S D Adley, R Willis, A C Mire, R M Jamison, K L McRae, J W King, W L Chang.   

Abstract

A better understanding of how human immunodeficiency virus (HIV) coinfection affects the course of hepatitis C virus (HCV) infection is required to select patients with HIV who would benefit from current HCV therapy. Between June 1996 and March 2000, HCV RNA levels were quantified for 1,279 patients at the Louisiana State University Health Sciences Center; 28 of these patients were coinfected with HIV. HCV loads were quantified by the Bayer branched-DNA assay with a lower limit of detection of 0.2 Meq/ml. We compared the median HCV RNA levels of for patients coinfected with HIV and HCV and patients infected only with HCV who were in the same age range (23 to 55 years). The median HCV load for the 28 patients coinfected with HCV and HIV (17.8 Meq/ml) was significantly greater (P < 0.05) than that for similarly aged patients infected only with HCV (6.1 Meq/ml). The HCV load did not correlate with age or sex for either group of patients. A significant (R = -0.4; P < 0.05) negative correlation was observed between HCV load and CD4 count in the coinfected group, for whom the CD4 counts at the time of HCV load analysis ranged from 6 to 1,773/mm(3). The increased HCV load in patients coinfected with HCV and HIV compared to that in patients infected only with HCV and the inverse relationship of the HCV load to the CD4 count indicate that immunosuppression results in decreased control of HCV replication. In addition, we report significantly higher HCV loads among coinfected African Americans than Caucasians.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427412      PMCID: PMC96128          DOI: 10.1128/CDLI.8.4.690-694.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  41 in total

1.  HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype.

Authors:  B Cribier; C Schmitt; D Rey; G Uhl; J M Lang; D Vetter; A Kirn; F Stoll-Keller
Journal:  Res Virol       Date:  1997 Jul-Aug

2.  Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.

Authors:  E Bierhoff; H P Fischer; E Willsch; J Rockstroh; U Spengler; H H Brackmann; J Oldenburg
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

3.  Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus.

Authors:  F Roudot-Thoraval; A Bastie; J M Pawlotsky; D Dhumeaux
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

4.  Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.

Authors:  M Beld; M Penning; V Lukashov; M McMorrow; M Roos; N Pakker; A van den Hoek; J Goudsmit
Journal:  Virology       Date:  1998-05-10       Impact factor: 3.616

5.  Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.

Authors:  G R Picchio; M Nakatsuno; C Boggiano; R Sabbe; M Corti; J Daruich; R Pérez-Bianco; M Tezanos-Pinto; R Kokka; J Wilber; D Mosier
Journal:  J Med Virol       Date:  1997-06       Impact factor: 2.327

6.  Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

Authors:  O T Rutschmann; F Negro; B Hirschel; A Hadengue; D Anwar; L H Perrin
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

Review 7.  Management of hepatitis C.

Authors: 
Journal:  NIH Consens Statement       Date:  1997 Mar 24-26

8.  Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection.

Authors:  G H Haydon; L M Jarvis; C S Blair; P Simmonds; D J Harrison; K J Simpson; P C Hayes
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

9.  Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features.

Authors:  L De Moliner; P Pontisso; G L De Salvo; L Cavalletto; L Chemello; A Alberti
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

10.  Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users.

Authors:  S Pol; B Lamorthe; N T Thi; V Thiers; F Carnot; H Zylberberg; P Berthelot; C Bréchot; B Nalpas
Journal:  J Hepatol       Date:  1998-06       Impact factor: 25.083

View more
  25 in total

Review 1.  Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections.

Authors:  K E Nelson; D L Thomas
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes.

Authors:  Alejandro Schijman; Rodney Colina; Sergey Mukomolov; Olga Kalinina; Laura García; Shobha Broor; Ajoy Varma Bhupatiraju; Peter Karayiannis; Baldip Khan; Cristina Mogdasy; Juan Cristina
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

Review 3.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 4.  Acute hepatitis C virus infection: a chronic problem.

Authors:  Jason T Blackard; M Tarek Shata; Norah J Shire; Kenneth E Sherman
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

5.  Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.

Authors:  Annie Luetkemeyer; C Bradley Hare; John Stansell; Phyllis C Tien; Edwin Charlesbois; Paula Lum; Diane Havlir; Marion Peters
Journal:  J Acquir Immune Defic Syndr       Date:  2006-01-01       Impact factor: 3.731

Review 6.  Substance abuse, HIV-1 and hepatitis.

Authors:  Nirzari Parikh; Michael R Nonnemacher; Vanessa Pirrone; Timothy Block; Anand Mehta; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2012-10       Impact factor: 1.581

7.  Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.

Authors:  Kenneth E Sherman; Norah J Shire; Susan D Rouster; Marion G Peters; Margaret James Koziel; Raymond T Chung; Paul S Horn
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

Review 8.  Acute hepatitis C in an HIV-infected patient: a case report and review of literature.

Authors:  Todd H Driver; Norah Terrault; Varun Saxena
Journal:  J Gen Intern Med       Date:  2012-11-14       Impact factor: 5.128

9.  Effect of HIV on liver fibrosis among HCV-infected African Americans.

Authors:  D Silver; G Karnik; A Osinusi; R Silk; L Stabinski; L Doonquah; S Henn; G Teferi; H Masur; S Kottilil; D Fishbein
Journal:  Clin Infect Dis       Date:  2013-02-01       Impact factor: 9.079

10.  Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men.

Authors:  Thijis van de Laar; Oliver Pybus; Sylvia Bruisten; David Brown; Mark Nelson; Sanjay Bhagani; Martin Vogel; Alex Baumgarten; Marie-Laure Chaix; Martin Fisher; Hannelore Gotz; Gail V Matthews; Stefan Neifer; Peter White; William Rawlinson; Stanislav Pol; Jurgen Rockstroh; Roel Coutinho; Greg J Dore; Geoffrey M Dusheiko; M Danta
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.